Pacira BioSciences (PCRX) Research & Development (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Research & Development of $28.1 million for Q1 2026, up 10.77% year-over-year from $25.3 million in Q1 2025, and down 25.05% quarter-over-quarter from $37.5 million in Q4 2025.
Pacira BioSciences (PCRX) Research & Development (2010 - 2026) Analysis & Trends
Pacira BioSciences' Research & Development history runs 17 years deep, the most recent figure standing at $28.1 million for Q1 2026.
- In Q1 2026, Research & Development rose 10.77% year-over-year to $28.1 million; the TTM figure through Mar 2026 stood at $119.7 million (up 34.97% YoY), while the FY2025 annual figure was $117.3 million, up 43.81% from the prior year.
- Research & Development for Q1 2026 stood at $28.1 million, down from $37.5 million in the prior quarter.
- The five-year high for Research & Development was $37.5 million in Q4 2025, with the low at $17.1 million in Q1 2023.
- The 5-year median for Research & Development is $20.8 million (2023), against an average of $22.8 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development soared 109.04% in 2022, then fell 28.38% in 2023.
- Pacira BioSciences' Research & Development stood at $17.5 million in 2022, then advanced by 11.19% to $19.5 million in 2023, then grew by 22.78% to $23.9 million in 2024, then jumped by 56.73% to $37.5 million in 2025, then slipped by 25.05% to $28.1 million in 2026.
- Business Quant data shows PCRX's Research & Development at $28.1 million in Q1 2026, $37.5 million in Q4 2025, and $26.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 948.27 Mn | 697.24 Mn | 148.24 Mn | 30.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.24 Mn |
| Mar 31, 2026 | 28.07 Mn |
| Dec 31, 2025 | 37.45 Mn |
| Sep 30, 2025 | 25.97 Mn |
| Jun 30, 2025 | 28.20 Mn |
| Mar 31, 2025 | 25.34 Mn |
| Dec 31, 2024 | 23.90 Mn |
| Sep 30, 2024 | 19.10 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Mar 31, 2024 | 18.24 Mn |
| Dec 31, 2023 | 19.46 Mn |
| Sep 30, 2023 | 20.83 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 17.14 Mn |
| Dec 31, 2022 | 17.51 Mn |
| Sep 30, 2022 | 19.41 Mn |
| Jun 30, 2022 | 26.28 Mn |
| Mar 31, 2022 | 21.61 Mn |
| Dec 31, 2021 | 15.51 Mn |
| Sep 30, 2021 | 11.58 Mn |